Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
CONCLUSION: During COVID period, there was a significant decrease in LTs performed for HCC. While early postoperative outcomes of LT for HCC were same, the overall and graft survival of LTs for HCC after 180 days were significantly inferior.PMID:37206654 | PMC:PMC10190691 | DOI:10.4254/wjh.v15.i4.554
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Inkyu S Lee Kenji Okumura Ryosuke Misawa Hiroshi Sogawa Gregory Veillette Devon John Thomas Diflo Seigo Nishida Abhay Dhand Source Type: research
More News: Alcoholism | Cancer & Oncology | Carcinoma | Coronavirus | COVID-19 | Databases & Libraries | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Pandemics | Statistics | Transplant Surgery | Transplants | Urology & Nephrology | USA Health